of compelling evidence that it reduces the morbidity associated with breast cancer (Austoker, 2003) . More than 30 nonrandomized trials have produced conflicting results about the efficacy of BSE (Harvey, Miller, Baines, & Corey, 1997) .
Confusion regarding BSE stems from many sources. Several methods have been suggested over the years, including vertical, strip, and circular (American Cancer Society, 2003a) . Of the agencies that recommend BSE, most suggest that it be done monthly, which is based on the menstrual cycle, despite the fact that most women who develop breast cancer are postmenopausal.
Women need to be informed about the limitations of BSE. The screening method is dependent on the skill of the women performing BSE. Women who examine their breasts more carefully and regularly may be able to detect subtle changes and achieve earlier diagnosis. When women detect abnormalities in their breasts, anxiety can be heightened. When BSE results in unnecessary biopsies, the method's financial costs are increased.
However, the regular practice of BSE has inherent strengths. Most importantly, it makes women aware of their own anatomy and the importance of engaging in the practice of early detection. Women may be able to detect subtle changes in the intervals between professional examinations (i.e., CBE and mammography, which usually are performed annually), which might lead to the earlier detection of lesions (Sterns, 1998) . The financial costs of BSE to women are negligible because it is performed in the privacy of their own homes at convenient times.
Will a randomized trial ever be conducted to evaluate the effectiveness of BSE? Conducting a trial in which women would be randomized to not practice BSE when it may indeed be beneficial would be ethically difficult. Many trials examining the efficacy of BSE have been conducted outside of the United States. Whether BSE might be beneficial in the United States because the incidence of breast cancer is higher is uncertain (Humphrey, Helfand, Chan, & Woolf, 2002) .
Clinical Breast Examination
CBE, like BSE, is a controversial screening tool. Few randomized CBE studies have been performed, and the method's quantitative effectiveness is unknown. CBE's sensitivity (the probability that the test result will be positive if breast cancer is present) has been reported to range from 40%-69%, and its specificity (the probability that the test result will be negative if breast cancer is not present) ranges from 88%-99% (Humphrey et al., 2002) . To date, no trial has examined the effectiveness of CBE as a sole breast cancer screening tool. Trials in which CBE was combined with mammography have demonstrated a mortality reduction of 14%-29% (Humphrey et al.) .
The usefulness of CBE in the early detection of breast cancer is, in part, related to the skill of the healthcare provider performing the examination. Competent, thorough providers may be more effective in detecting clinical changes. When CBE is performed prior to mammography, it may be useful in identifying an area of suspicion that might This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints, please e-mail reprints@ons.org or to request permission to reproduce multiple copies, please e-mail pubpermissions@ons.org. not be readily visible on mammography or providing guidance in selecting additional imaging techniques, such as ultrasound . As with BSE, the biggest benefit of CBE probably is that it heightens awareness about the early detection of breast cancer and provides an opportunity to further educate women about early detection and prevention strategies.
Mammography
Most research related to the early detection of breast cancer focuses on the use of mammography. The primary evidence that supports mammography comes from seven large randomized clinical trials that found a statistically significant mortality reduction from breast cancer in women aged 40-69 who underwent regular screening mammography . Overall, the trials suggested that a 24% mortality reduction is associated with mammography use. Some of the trials involved annual screening, and others used a two-year interval. Evidence now suggests that the benefit of annual screening may be greater in premenopausal women (Smith et al.) .
Mammography is not without limitations. Some women find mammography to be very uncomfortable. Although the amount of radiation exposure is small, it does occur. Every woman needs to be educated about the risks. Mammography does not achieve perfect sensitivity or specificity. Sensitivity for annual mammography ranges from 71%-96%, with less sensitivity observed in younger women (Humphrey et al., 2002) . Specificity ranges from 94%-97%. False-negative mammograms occur because of technologic limitations of equipment and film, quality-assurance failures, and human errors. False-positive mammograms can be attributed to these issues, as well as concern over legal liability . Technical limitations may be related to the women being tested. Younger women, significant risk factors, breast density, hormone use, and tumor growth rates may limit the sensitivity of a mammogram. Women need to be instructed about the possibility of having false-negative or false-positive films.
When abnormalities are detected by mammography, further evaluation is needed. Additional testing contributes to higher medical care costs. The 10-year probability of a false-positive results for a 60-year-old woman having an annual screening mammogram is 47%, and the probability of a false-positive mammogram leading to a biopsy is 19% (Smith, 2003) . Another concern associated with the use of mammography is increased detection and possible overtreatment of ductal carcinoma in situ . The psychosocial costs and anxiety associated with false positive mammograms cannot be ignored. Research findings suggest that little evidence exists of lasting anxiety or negative attitudes toward future mammographic screening (Smith) .
Implications for Nurses
First, nurses should review the scientific bases for each of these breast cancer screening guidelines. Each agency that issues a guideline should make this information available. To obtain information about the scientific bases and review processes for guidelines, contact the individual agencies that generated them or the National Guideline Clearinghouse, available online at www.guideline.gov.
Second, nurses have a key role in interpreting data about screening to women. Nurses should explain why a particular set of guidelines is being used for each woman. They should remind women that these are guidelines and that some modifications may be made based on assessment of risk factors and findings on clinical examination. With some women who are in declining health, nurses may discuss discontinuing breast cancer screening, although none of the guidelines provides specific direction in this area. Clearly, the benefits, risks, and potential limitations of BSE, CBE, and mammography must be discussed with each woman and tailored to assessment of her risk factors.
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